ArticleAdvances in therapy2024

Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC.

Konstantinos Arnaoutakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.